D.E. Shaw & Co
ABEO icon

D.E. Shaw & Co’s Abeona Therapeutics ABEO Stock Holding History

D.E. Shaw & Co’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Sell
57,100
-43,965
-44% -$241K ﹤0.01% 4343
2026
Q1 		$453K Sell
101,065
-4,900
-5% -$24.5K ﹤0.01% 3898
2025
Q4 		$558K Sell
105,965
-20,419
-16% -$103K ﹤0.01% 3872
2025
Q3 		$667K Buy
+126,384
New +$802K ﹤0.01% 3707
2022
Q3 		– Sell
-49,220
Closed -$256K – 5138
2022
Q2 		$256K Sell
49,220
-32,146
-40% -$163K ﹤0.01% 4429
2022
Q1 		$641K Sell
81,366
-19,380
-19% -$133K ﹤0.01% 4221
2021
Q4 		$849K Buy
+100,746
New +$1.85M ﹤0.01% 4063
2021
Q1 		– Sell
-3,331
Closed -$131K – 3985
2020
Q4 		$131K Sell
3,331
-5,043
-60% -$172K ﹤0.01% 3786
2020
Q3 		$214K Buy
8,374
+949
+13% +$59.8K ﹤0.01% 3576
2020
Q2 		$541K Sell
7,425
-1,770
-19% -$122K ﹤0.01% 3315
2020
Q1 		$483K Sell
9,195
-1,123
-11% -$75K ﹤0.01% 3230
2019
Q4 		$843K Buy
10,318
+4,226
+69% +$298K ﹤0.01% 3093
2019
Q3 		$344K Buy
6,092
+5,595
+1,126% +$419K ﹤0.01% 3388
2019
Q2 		$59K Buy
+497
New +$83.3K ﹤0.01% 3578
2016
Q4 		– Sell
-497
Closed -$75K – 3406
2016
Q3 		$75K Buy
+497
New +$48.6K ﹤0.01% 3306
2016
Q1 		– Sell
-520
Closed -$44K – 3367
2015
Q4 		$44K Buy
+520
New +$52.2K ﹤0.01% 3719

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

D.E. Shaw & Co's ABEO Position: Q2 2026 in Review

D.E. Shaw & Co reduced its Abeona Therapeutics (ABEO) stake by 44% in Q2 2026, selling an estimated $241K and leaving 57,100 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #4343.

D.E. Shaw & Co first reported a position in ABEO in Q4 2015 and has held it in 16 quarters since. The position peaked at $849K in Q4 2021. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • D.E. Shaw & Co held 57,100 shares of Abeona Therapeutics worth $353K as of Q2 2026.
  • D.E. Shaw & Co sold 43,965 Abeona Therapeutics shares in Q2 2026, an estimated $241K.
  • Abeona Therapeutics made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #4343 holding.
  • D.E. Shaw & Co first reported a position in Abeona Therapeutics in Q4 2015 and has held it in 16 quarters since.
  • D.E. Shaw & Co's Abeona Therapeutics position peaked at $849K in Q4 2021.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.